Doctors implanted a microchip into a paralyzed patient's brain as part of a clinical trial giving people the ability to ...

Amyotrophic lateral sclerosis most often starts between the ages of 40 to 70, and people usually survive for 2 to 5 years after their diagnosis. My ALS Story. By Fred Shank, ...

The amount of lives that he touched and changed for the better number in the thousands," his stepdaughter wrote.

BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...

Amyotrophic lateral sclerosis (ALS) affects certain motor nerve cells in the spinal cord. People with ALS gradually lose the ability to walk, talk, eat, swallow, and perform other motor functions.

Commonly prescribed medications for anxiety, depression and sleep disorders may be associated with a higher risk of ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and central nervous system (CNS) diseases, today ...

Tim Cronin, a founding member of Monster Magnet, has died, aged 63. Cronin had been diagnosed earlier this year with ALS ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the loss of cortical and spinal motor neurons, leading to weakness, muscle atrophy, and, in a substantial ...

Amyotrophic lateral sclerosis (ALS) is a devastating disease with poorly understood causes and no known cure. But research is slowly beginning to bring hope to those affected. This Outlook ...

Explore Our Free-Market Analysis Sample – Instant Access: – https://www.astuteanalytica.com/request-sample/amyotrophic-lateral-sclerosis-treatment-market ...